Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
10.89
-0.43 (-3.80%)
Nov 20, 2026, 3:04 PM CST
SHE:002020 Revenue
Zhejiang Jingxin Pharmaceutical had revenue of 1.05B CNY in the quarter ending September 30, 2026, with 1.63% growth. This brings the company's total for the last twelve months to 4.06B, up 1.47% year-over-year. In the year 2025, Zhejiang Jingxin Pharmaceutical had annual revenue of 4.07B, down -2.14%. That makes Zhejiang Jingxin Pharmaceutical the 10,169th largest company in the world by revenue and 1,652nd in China.
Revenue (ttm)
4.06B
Revenue Growth
+1.47%
P/S Ratio
2.18
Revenue / Employee
1.09M
Employees
3,732
Market Cap
8.86B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:002020 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.07B | -89.19M | -2.14% |
| Dec 31, 2024 | 4.16B | 159.72M | 3.99% |
| Dec 31, 2023 | 4.00B | 218.99M | 5.79% |
| Jan 1, 2023 | 3.78B | 313.30M | 9.04% |
| Jan 1, 2022 | 3.47B | 208.47M | 6.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.